52North logo
52North logo

52North

52north.health
52north.health • Venture - Series Unknown 2026 • Founded 2018 • Startup • New
Venture - Series Unknown 2026 • Founded 2018 • Startup • New
Actively hiring
Health Care
As featured in
IFA Magazine
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$4.1M
1 round on record
Latest round
$4.1M
Venture round · Sep 2026 · this month
Backers
2
Cambridge Angels, Future Planet Capital
The money's age
Fresh money
0 months since the last round · not hiring
Momentum
35/100
in the news, fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 29 Raised a round Venture round $4.1M · led by Macmillan Cancer Support · IFA Magazine 2018 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Sep 2026 $4.1M Macmillan Cancer Support lead, Hargreave Hale AIM VCT lead IFA Magazine
Backed byfrom the funds' portfolios and accelerator catalogs
Cambridge Angels fund Future Planet Capital fund
Similar startupsby what they do, their industry and backers
Kalium Health51-200 employees
Kalium Health | Precision testing to transform the management of chronic kidney disease and heart disease.
Nuance Pharma501-1000 employees
Nuance Pharma are an innovation focused biopharmaceutical company, with both late-stage clinical pipeline and commercial stage asset…
UltrahumanFounded 2020
Ultrahuman is a health and fitness app that helps users to achieve their respective health goals. It helps people to transform themselves…
BiomesenseConvertible Note $7.1M · 14 mo ago • Founded 2018 • 51-200 employees
BiomeSense develops advanced microbiome analytics technology to transform healthcare, research, and diagnostics with real-time insights.
ImplantlyFounded 2021 • 11-50 employees
Transform your smile with full mouth dental implants. Expert care, advanced technology, and affordable treatment for lasting, natural…
KAI Conversations
Transform pharmaceutical conversations with KAI's AI-powered conversation intelligence platform.

Overview

We build innovative diagnostic and digital solutions to transform emergency care.

News

News IFA Magazine 2 days ago
52North raises £3.2 million to transform urgent cancer care, with funding co-led by Macmillan Cancer Support and Hargreave Hale AIM VCT
52North, the University of Cambridge spin-out behind the Aster biomarker platform, has secured £3.2 million in new funding to accelerate its mission
Read more
Report

Financials

Total raised
$4.1M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2026 $4.1M Details